Friday, 2 September 2011

New Study Is The First North American Clinical Trial To Test Adult Mesenchymal Stem Cell Transplantation As A New Therapy For MS


Source Medical News Today:
A team of researchers at three landmark Cleveland institutions have come together to launch a new clinical trial of an experimental treatment for multiple sclerosis (MS). Researchers at the Cleveland Clinic, University Hospitals Seidman Cancer Center, and Case Western Reserve University are collaborating on a ground-breaking study that will test the feasibility and safety of using the body's own stem cells to treat MS. Read more here!